Ebina, Teresita P.
HRN: 21-84-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/01/2023
09/08/2023
IV
2.25g
Q6
CAP MR
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines